AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24840143 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EG) received weekly patient progress feedback (OQ-45) and clinical support tools (CST) starting at t2.
Number of subjects: 252
Study 24840143 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) received treatment-as-usual without additional feedback or tools.
Number of subjects: 252
Study 22547605 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib alone (arm A)
Number of subjects: 181
Study 22547605 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib plus carboplatin and paclitaxel (ECP) (arm B)
Number of subjects: 181
Study 19397816 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment methods (media techniques, direct contact, health care provider contacts)
Number of subjects: 58
Study 17462986 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal and child health and family planning program initiated in Matlab in 1977
Number of subjects: 0
Study 17462986 — intervention group
Group type: COMPARATOR
Intervention: Comparison area (no specific intervention mentioned)
Number of subjects: 0
Study 15986722 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurorehabilitation
Number of subjects: 6783
Study 15986722 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rehabilitation 'B'
Number of subjects: 6783
Study 15986722 — intervention group
Group type: EXPERIMENTAL
Intervention: GOS scores
Number of subjects: 6783
Study 15986722 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of rehabilitation
Number of subjects: 6783
Study 15986722 — intervention group
Group type: EXPERIMENTAL
Intervention: GCS and GOS assessment
Number of subjects: 6783
Study 11476474 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen-specific immunotherapy (SIT)
Number of subjects: 0
Study 9415087 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted learning (CAL) programs in addition to daily formal teaching
Number of subjects: 26
Study 9415087 — intervention group
Group type: COMPARATOR
Intervention: Daily formal teaching only (Control)
Number of subjects: 26
Study 7937658 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing Exercises (BE)
Number of subjects: 36
Study 7937658 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (Y)
Number of subjects: 36
Study 7937658 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 36
Study 3107721 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestrinone
Number of subjects: 37
Study 3107721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 3107721 — intervention group
Group type: EXPERIMENTAL
Intervention: No visible endometriosis
Number of subjects: 37
Study 3107721 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual endometriosis
Number of subjects: 37
Study 3107721 — intervention group
Group type: COMPARATOR
Intervention: Control group (unexplained infertility)
Number of subjects: 37
Study 31758326 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 171
Study 31758326 — intervention group
Group type: EXPERIMENTAL
Intervention: HPR Plus™
Number of subjects: 171
Study 31758326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 29696919 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with rehabilitation training
Number of subjects: 60
Study 29696919 — intervention group
Group type: COMPARATOR
Intervention: Low-frequency electrical therapy combined with rehabilitation training
Number of subjects: 60
Study 25988390 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided SIJ injection
Number of subjects: 40
Study 25988390 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopy-guided SIJ injection
Number of subjects: 40
Study 25583842 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote cognitive assessment using the Symbol Digit Modalities Test (SDMT)
Number of subjects: 24
Study 25583842 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote cognitive assessment using the Automated Neuropsychological Assessment Metrics (ANAM‐MS)
Number of subjects: 24
Study 25583842 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth testing sessions
Number of subjects: 24
Study 23884388 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-biofortified millet meals
Number of subjects: 20
Study 23884388 — intervention group
Group type: COMPARATOR
Intervention: Regular-iron millet meals
Number of subjects: 20
Study 23884388 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-harvest iron-fortified millet meals
Number of subjects: 20
Study 20873904 — intervention group
Group type: EXPERIMENTAL
Intervention: Capnometry‐assisted respiratory training
Number of subjects: 41
Study 20873904 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 41
Study 18442966 — intervention group
Group type: COMPARATOR
Intervention: CPVI group (n = 54)
Number of subjects: 106
Study 18442966 — intervention group
Group type: EXPERIMENTAL
Intervention: CPVI + SVCI group (n = 52)
Number of subjects: 106
Study 16874169 — intervention group
Group type: COMPARATOR
Intervention: Pneumococcal conjugate vaccine (not received)
Number of subjects: 1009
Study 16874169 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal infection
Number of subjects: 1009
Study 16874169 — intervention group
Group type: EXPERIMENTAL
Intervention: NTS infections
Number of subjects: 1009
Study 14571103 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Carnitine (2 g twice a day)
Number of subjects: 120
Study 14571103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 14571103 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Carnitine
Number of subjects: 120
Study 10952323 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin group
Number of subjects: 39
Study 10952323 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 9308260 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride released from Rely-a-Bond adhesive
Number of subjects: 50
Study 9308260 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fluoride in adhesive)
Number of subjects: 50
Study 8481936 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with SIADH (n=19)
Number of subjects: 31
Study 8481936 — intervention group
Group type: COMPARATOR
Intervention: Children without SIADH (n=12)
Number of subjects: 31
Study 8481936 — intervention group
Group type: EXPERIMENTAL
Intervention: 23 children measured for Mean arterial pressure (MAP)
Number of subjects: 31
Study 3555129 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 hours of daily continuous passive motion (CPM) starting on the 2nd postoperative day
Number of subjects: 18
Study 3555129 — intervention group
Group type: COMPARATOR
Intervention: Delayed motion using a soft hinged knee brace locked at 10 degrees of flexion, starting on the 7th postoperative day
Number of subjects: 18
Study 3555129 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (motion and delayed motion)
Number of subjects: 18
Study 31892475 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission protocol for intervention group
Number of subjects: 200
Study 31892475 — intervention group
Group type: COMPARATOR
Intervention: Admission by staff midwives and doctors for control group
Number of subjects: 200
Study 31825939 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 366
Study 27470931 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Sprint and Strength Training (HISST) for 13 weeks in young training group (YT)
Number of subjects: 36
Study 27470931 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Sprint and Strength Training (HISST) for 13 weeks in middle-aged training group (AT)
Number of subjects: 36
Study 27470931 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Sprint and Strength Training (HISST)
Number of subjects: 36
Study 27470931 — intervention group
Group type: COMPARATOR
Intervention: Control group (young control group YC and middle-aged control group AC)
Number of subjects: 36
Study 26003931 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive Outreach (AO) intervention
Number of subjects: 318
Study 26003931 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 318
Study 24106997 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone and SMS intervention in addition to usual care
Number of subjects: 180
Study 24106997 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 180
Study 21323520 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib and gemcitabine
Number of subjects: 26
Study 19487625 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotics (clozapine, risperidone, or olanzapine)
Number of subjects: 46
Study 19487625 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (a D(3) receptor-preferring agonist)
Number of subjects: 46
Study 19487625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 17554158 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational junior-sport model combining skills from rugby, cricket, and netball
Number of subjects: 0
Study 17554158 — intervention group
Group type: COMPARATOR
Intervention: Modified games model
Number of subjects: 0
Study 17554158 — intervention group
Group type: EXPERIMENTAL
Intervention: Both models
Number of subjects: 0
Study 15531659 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil plus antioxidants (2.7 g EPA and DHA/d)
Number of subjects: 62
Study 15531659 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 62
Study 11417430 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of 19‐nor‐4‐androstene‐3,17‐dione and 56 mg of 19‐nor‐4‐androstene‐3,17‐diol (156 mg total norsteroid per day)
Number of subjects: 0
Study 11417430 — intervention group
Group type: COMPARATOR
Intervention: Placebo (a multivitamin)
Number of subjects: 0
Study 9893540 — intervention group
Group type: EXPERIMENTAL
Intervention: fentanyl 2 micrograms.kg-1 + ketamine 0.25 mg.kg-1
Number of subjects: 8
Study 9893540 — intervention group
Group type: COMPARATOR
Intervention: fentanyl 2 micrograms.kg-1 + placebo
Number of subjects: 8
Study 8031484 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonicare electronic toothbrush
Number of subjects: 49
Study 8031484 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (Oral-B P-35)
Number of subjects: 49
Study 8031484 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (Crest Complete)
Number of subjects: 49
Study 2525758 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP)
Number of subjects: 130
Study 2525758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 7972859 — intervention group
Group type: EXPERIMENTAL
Intervention: High-potency neuroleptics treatment for 3 weeks
Number of subjects: 33
Study 7972859 — intervention group
Group type: COMPARATOR
Intervention: Control group (no neuroleptic treatment)
Number of subjects: 33
Study 355071 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 64
Study 355071 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 64
Study 31118098 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum-based fortifier
Number of subjects: 200
Study 31118098 — intervention group
Group type: COMPARATOR
Intervention: Bovine milk-based fortifier
Number of subjects: 200
Study 27988288 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Exchange (WE)
Number of subjects: 651
Study 27988288 — intervention group
Group type: COMPARATOR
Intervention: Air Insufflation (AI)
Number of subjects: 651
Study 27988288 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Immersion (WI)
Number of subjects: 651
Study 25426617 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (15 mg/kg on day 1 for one 3-week cycle)
Number of subjects: 0
Study 25426617 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Bevacizumab and Everolimus
Number of subjects: 0
Study 25426617 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (10 mg daily)
Number of subjects: 0
Study 23310947 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients (BMI ≥ 30 kg/m²)
Number of subjects: 25291
Study 23310947 — intervention group
Group type: EXPERIMENTAL
Intervention: Underweight patients (BMI < 18.5 kg/m²)
Number of subjects: 25291
Study 23310947 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with class 2 and 3 obesity (BMI ≥ 35.0 kg/m²)
Number of subjects: 25291
Study 21439112 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent endoscopic cleaning
Number of subjects: 24
Study 21439112 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention
Number of subjects: 24
Study 19458109 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparins (LMWHs)
Number of subjects: 0
Study 19458109 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-Xa activity monitoring
Number of subjects: 0
Study 17394699 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5alpha-reductase inhibitor)
Number of subjects: 0
Study 17394699 — intervention group
Group type: COMPARATOR
Intervention: Dutasteride
Number of subjects: 0
Study 17394699 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E and Selenium
Number of subjects: 0
Study 15952679 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion in combination with canal injection for local anaesthesia with Mepivacaine 2% and Adrenalin 1/100,000
Number of subjects: 92
Study 15952679 — intervention group
Group type: COMPARATOR
Intervention: Local anaesthetic by infiltration of the external canal ear
Number of subjects: 92
Study 12364308 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes to the order of presenting treatments, improved presentation of information, and redefinition of the non-radical arm.
Number of subjects: 0
Study 9667262 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated-liposomal doxorubicin (20 mg/m2)
Number of subjects: 258
Study 9667262 — intervention group
Group type: COMPARATOR
Intervention: Combination of doxorubicin (20 mg/m2), bleomycin (10 mg/m2), and vincristine (1 mg) (ABV)
Number of subjects: 258
Study 8110579 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg or 30 mg i.m., 6 hourly
Number of subjects: 75
Study 8110579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 2530869 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg amlodipine administered intravenously
Number of subjects: 18
Study 2530869 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 18
Study 1193329 — intervention group
Group type: EXPERIMENTAL
Intervention: chenodeoxycholic acid
Number of subjects: 6
Study 1193329 — intervention group
Group type: COMPARATOR
Intervention: cholic acid
Number of subjects: 6
Study 1193329 — intervention group
Group type: COMPARATOR
Intervention: pretreatment period
Number of subjects: 6
Study 30894148 — intervention group
Group type: EXPERIMENTAL
Intervention: Humor training
Number of subjects: 37
Study 30894148 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 37
Study 28392080 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose loop diuretic strategy (HDLD-strategy)
Number of subjects: 308
Study 25409951 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol PR (prolonged release)
Number of subjects: 99
Study 23305630 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention group (Group B) consuming ≥ 9 servings/day of selected vegetables, fruit and culinary herbs with bone resorbing inhibiting properties.
Number of subjects: 100
Study 23305630 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (Control Group C) with 50 women.
Number of subjects: 100
Study 21994424 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0941 10 mg
Number of subjects: 587
Study 21994424 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0941 20 mg
Number of subjects: 587
Study 21994424 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0941 30 mg
Number of subjects: 587
Study 21994424 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0941 40 mg
Number of subjects: 587
Study 21994424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 587
Study 21994424 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0941 (all doses)
Number of subjects: 587
Study 18513233 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% UVB sunbed sessions (4 sessions of 6 minutes each on days 0, 2, 4, and 7)
Number of subjects: 56
Study 18513233 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4% UVB sunbed sessions (4 sessions of 12 minutes each on days 9, 11, 14, and 16)
Number of subjects: 56
Study 18513233 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 56
Study 16869927 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental groups with modified CBE programme
Number of subjects: 0
Study 16869927 — intervention group
Group type: COMPARATOR
Intervention: Conventional groups with standard CBE programme
Number of subjects: 0
Study 12492802 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 40 micro g kg‐1
Number of subjects: 120
Study 12492802 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 40 micro g kg‐1 plus dexamethasone 8 mg
Number of subjects: 120
Study 11311839 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotapes and written materials under different conditions of presentation
Number of subjects: 624
Study 9712230 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine 60 mg orally
Number of subjects: 55
Study 9712230 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects (29 subjects) matched for sex and age
Number of subjects: 55
Study 7986437 — intervention group
Group type: EXPERIMENTAL
Intervention: Caulk Prisma AP.H/Prisma Universal Bond resin composite restorative system
Number of subjects: 60
Study 2610719 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg modafinil
Number of subjects: 10
Study 2610719 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg modafinil
Number of subjects: 10
Study 2610719 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg d-amphetamine
Number of subjects: 10
Study 2610719 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg d-amphetamine
Number of subjects: 10
Study 2610719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 1089884 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ambulation (mobilized on day six)
Number of subjects: 129
Study 1089884 — intervention group
Group type: COMPARATOR
Intervention: Late ambulation (mobilized on day 13)
Number of subjects: 129
Study 1089884 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with complications before day six (early ambulation)
Number of subjects: 129
Study 1089884 — intervention group
Group type: COMPARATOR
Intervention: Patients with complications before day six (late ambulation)
Number of subjects: 129
Study 1089884 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ambulation
Number of subjects: 129
Study 1089884 — intervention group
Group type: COMPARATOR
Intervention: Late ambulation
Number of subjects: 129
Study 30594608 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting program
Number of subjects: 0
Study 30006653 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal lavage with saline solution at room temperature (20 °C)
Number of subjects: 78
Study 30006653 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal lavage with saline solution at body temperature (37 °C)
Number of subjects: 78
Study 26825032 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc intensification
Number of subjects: 17
Study 26825032 — intervention group
Group type: COMPARATOR
Intervention: Control arm (existing cART regimen)
Number of subjects: 17
Study 24216624 — intervention group
Group type: EXPERIMENTAL
Intervention: Stevia extracts (stevioside, rebaudioside A)
Number of subjects: 20
Study 24216624 — intervention group
Group type: COMPARATOR
Intervention: Sucrose solution
Number of subjects: 20
Study 22023518 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab-containing therapy before transformation
Number of subjects: 18
Study 22023518 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab-containing therapy after transformation
Number of subjects: 18
Study 22023518 — intervention group
Group type: COMPARATOR
Intervention: No rituximab pre-transformation
Number of subjects: 18
Study 22023518 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab pre-transformation
Number of subjects: 18
Study 18766955 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 2 mg/kg/day for 12 weeks
Number of subjects: 24
Study 17979861 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-arm bimanual intensive therapy (HABIT); 6 hours per day for 10 days.
Number of subjects: 20
Study 17979861 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control group; no specific intervention mentioned.
Number of subjects: 20
Study 14766494 — intervention group
Group type: EXPERIMENTAL
Intervention: Random practice schedule (intermixed, unsystematic sequence)
Number of subjects: 172
Study 14766494 — intervention group
Group type: COMPARATOR
Intervention: Blocked practice schedule (each letter or symbol handwritten 24 times consecutively)
Number of subjects: 172
Study 11822991 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 0
Study 11822991 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP)
Number of subjects: 0
Study 11822991 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined nefazodone/CBASP
Number of subjects: 0
Study 11822991 — intervention group
Group type: COMPARATOR
Intervention: CBASP
Number of subjects: 0
Study 10102781 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,4-methylenedioxyethylamphetamine (MDE)
Number of subjects: 32
Study 10102781 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 32
Study 10102781 — intervention group
Group type: EXPERIMENTAL
Intervention: d-methamphetamine
Number of subjects: 32
Study 10102781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 8848903 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 250 micrograms (n = 18)
Number of subjects: 51
Study 8848903 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine 25 mg (n = 18)
Number of subjects: 51